Tema Sinergie Competitors and Similar CompaniesClear all

Tema Sinergie's competitors and similar companies include Acelity, Viemed Healthcare, Endologix and Shanghai Sanyou Medical.

	Tema Sinergie Tema Sinergie is a company that designs, produces, and services shielded equipment and measuring instruments for the safe use of radioactive materials.	Acelity Acelity is a medical device company offering wound therapeutics products.	Viemed Healthcare Viemed Healthcare is a company that provides equipment and home respiratory services to patients struggling with respiratory diseases.	Endologix Endologix is a medical device company that provides therapies for the treatment of vascular disease.	Shanghai Sanyou Medical Shanghai Sanyou Medical (上海三友医疗器械股份有限公司) researches, develops, manufactures, and supplies orthopedics implant products.
Founding Date	Founding Date 1985	Founding Date 1976	Founding Date 2006	Founding Date 1992	Founding Date 2005
Type	Type Private	Type Subsidiary	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech medical devices medtech	Tags Healthcare medical devices therapy	Tags Healthcare medical devices therapy	Tags Healthcare medical devices therapy	Tags Healthcare medical devices therapy
Locations	Locations Faenza, IT HQ	Locations San Antonio, US HQ Lane Cove West, AU Wien, AT Wien, AT Mississauga, CA see more	Locations Baton Rouge, US HQ	Locations Irvine, US HQ 's Hertogenbosch, NL Milpitas, US Santa Rosa, US	Locations CN HQ
Employees	Employees 2613% increase	Employees 2,106	Employees 765	Employees 4351% increase	Employees 466
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 351.4 m	Valuation ($) N/A	Valuation ($) 752.5 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $270.3m (FY, 2025)	Revenue (est.) $143.4m (FY, 2019)	Revenue (est.) ¥446m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $114.8m (FY, 2025)	Cost of goods $52.3m (FY, 2019)	Cost of goods ¥130m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $155.5m (FY, 2025)	Gross profit $91.1m (FY, 2019)	Gross profit ¥317.9m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income $15.4m (FY, 2025)	Net income ($64.8m) (FY, 2019)	Net income ¥12.1m (FY, 2024)